Patent US4070576A successfully refreshed from Google Patents.
US4070576A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Detecting malignant cells
Assignee: UNITED STATES TRUST Co
•
Filing: 1976-02-02
•
Granted: 1978-01-24
•
Expires: 1996-02-02
Abstract
Abstract The detection of malignant or dysplastic cells in a tissue sample, by treating the sample with a solution containing radioactive gallium and relying upon the greater take-up of the gallium by the malignant or dysplastic cells relative to normal cells to provide a detectable signal of malignancy, is improved by including non-radioactive preemptive species in the solution to pre-empt potential gallium binding sites in protein molecules of normal cells. The pre-emptive species may be one or more of scandium, indium or yttrium.
Inventors
- 👤 Carolus M. Cobb
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 12:05
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/02; C12Q1/04; C12Q1/16; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/60
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
125 words
Cytological examination method comprising, suspending a cell population in a carrier fluid together with a radioactive tracer species which is linkable to both normal and abnormal cells, but more readily to one than the other, in essentially repeatable differential uptake pattern, further incorporating in said such suspension a preemptive species which pre-emptively links to the type of cell which is less readily linked by the tracer species to enhance the pattern of differential uptake of tracer by suspended cells, and measuring radioactivity of separate portions of the cell population to produce decay count data based on extent of tracer pickup by each such portion, wherein the tracer species is gallium and the pre-emptive species is selected from the class consisting of indium, yttrium and scandium.
Claim 2
Dependent Claim
125 words
Cytological examination method comprising, suspending a cell population in a carrier fluid together with a radioactive tracer species which is linkable to both normal and abnormal cells, but more readily to one than the other, in essentially repeatable differential uptake pattern, further incorporating in said such suspension a preemptive species which pre-emptively links to the type of cell which is less readily linked by the tracer species to enhance the pattern of differential uptake of tracer by suspended cells, and measuring radioactivity of separate portions of the cell population to produce decay count data based on extent of tracer pickup by each such portion, wherein the tracer species is gallium and the pre-emptive species is selected from the class consisting of indium, yttrium and scandium.
Claim 3
Dependent Claim
14 words
Cytological examination method in accordance with claim 1 where said pre-emptive species is scandium.
Claim 4
Dependent Claim
16 words
Cytological examination method in accordance with claim 1 wherein said separate cell portions comprise single cells.
Claim 5
Dependent Claim
26 words
Cytological examination method in accordance with claim 1 wherein the formula weight ratio of pre-emptive species to tracer species in said fluid is at least 1000:1.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-01-23 | 1981-07-25 | 1982-01-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-01-23 | 1985-07-25 | 1986-01-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-01-23 | 1989-07-25 | 1990-01-24 | $7700.00 | Window Closed / Lapsed |